ClinicalTrials.gov
public full text
Public Domain
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
This is a 15 week trial to determine (1) the safety and tolerability of varenicline when used for smoking cessation/reduction in individuals with schizophrenia; (2) if treatment with varenicline affects the symptoms of schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder#805707
- Varenicline In-Patient Study#1086693
- Varenicline Effects In Schizophrenic Smokers#895660
- Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis#979911
- A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline#1074986
Record · ID 804376
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive